Insider Transactions in Q4 2022 at Salarius Pharmaceuticals, Inc. (SLRX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Nov 03 2022	Mark J Rosenblum Exec VP Finance, CFO	BUY Grant, award, or other acquisition	Direct	7,314 +4.49%	$7,314 $1.73 P/Share
Nov 03 2022	David J. Arthur Chief Executive Officer	BUY Grant, award, or other acquisition	Direct	10,000 +3.38%	$10,000 $1.73 P/Share

Receive a notification when an Institution or Guru buys or sells SLRX shares.

Notify only if

Value

Get notified when an Salarius Pharmaceuticals, Inc. insider buys or sells SLRX shares.

Notify only if

Operation

Value

Type

Receive news related to Salarius Pharmaceuticals, Inc.